Black Swift Group’s United Therapeutics UTHR Stock Holding History

Black Swift Group’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$271K	Hold	500	–	–	0.04%	131
2026 Q1	$296K	Buy	+500	New	+$249K	0.05%	105

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Black Swift Group's UTHR Position: Q2 2026 in Review

Black Swift Group held its United Therapeutics (UTHR) position steady in Q2 2026 at 500 shares worth $271K. The position accounts for 0.04% of the portfolio, ranked #131.

Black Swift Group first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. The position peaked at $296K in Q1 2026. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Black Swift Group held 500 shares of United Therapeutics worth $271K as of Q2 2026.
Black Swift Group left its United Therapeutics share count unchanged in Q2 2026.
United Therapeutics made up 0.04% of Black Swift Group's portfolio in Q2 2026, its #131 holding.
Black Swift Group first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
Black Swift Group's United Therapeutics position peaked at $296K in Q1 2026.
878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Black Swift Group's 13F filing for Q2 2026, filed 13 Aug 2026.